Naoki Yoshikawa

2PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 26, 2025
Edaravone is a Therapeutic Candidate for Doxorubicin-Induced Cardiomyopathy by Activating the Nrf2 Pathway.

Naoki Yoshikawa, Naoto Hirata, Yuichiro Kurone

|Dec 11, 2023
Red Ginseng Is a Therapeutic Candidate for Chronic Doxorubicin-Induced Cardiomyopathy in Mice.

Naoki Yoshikawa, Naoto Hirata, Yuichiro Kurone

Pageof 1

Frequent Collaborators